What Is Driving Global Automation In Biopharma Industry Market Growth in 2025: The Role of Rising Role Of Robotics In Pharmaceutical Manufacturing Fuels Expansion Of Automation In The Biopharma Industry

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Automation In Biopharma Industry Market Size Growth Forecast: What to Expect by 2025?
The overall valuation of the automation sector within the biopharma industry has shown robust expansion lately, projected to climb from a figure of $2.08 billion in 2024 to reach $2.19 billion by 2025, reflecting a consistent compound annual growth rate (CAGR) totaling 5.6%. This upward trajectory observed during the past period stems from several key factors: the escalating intricacy associated with biopharmaceutical workflows, the imperative for enhancements in operational throughput, the expansion in the creation and production of biologic drugs, the rising requirement for stringent quality verification and oversight, and the competitive impetus to accelerate the introduction of products to the market.

How Will the Automation In Biopharma Industry Market Size Evolve and Grow by 2029?
Anticipation surrounds the biopharma sector's automation market, projecting considerable expansion in the forthcoming years, escalating to an estimated $2.92 billion by 2029, propelled by a compound annual growth rate of 7.4%. This upward trajectory during the forecast timeframe is fundamentally driven by several key factors, including improved data dependability and record-keeping, the increasing prevalence of individualized medical treatments, the emergence of adaptable and modular bioprocessing setups, continuous progression in automation systems, escalating needs for biosimilar products, and the broader uptake of smart sensing devices and the Internet of Things (IoT). Significant shifts shaping this era involve progress in robotic and automated methodologies, breakthroughs in technologies utilizing disposable components, the incorporation of artificial intelligence across bioprocessing workflows, forward movement in process analytical technologies (PAT), increasing partnerships among biopharma entities and tech firms, and a greater focus on environmentally conscious practices within biopharma automation efforts.

View the full report here:
https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

What Drivers Are Propelling the Growth of Automation In Biopharma Industry Market Forward?
The expanding integration of robotic solutions within pharmaceutical production settings is anticipated to spur market development for automation across the biopharma sector. These pharmaceutical manufacturing robots encompass sophisticated, mechanized apparatuses designed to execute diverse operational functions throughout the creation and boxing of medicinal goods. Robots find utility across numerous pharmaceutical activities, spanning from final packaging stages and internal material handling to laboratory procedures, precise item manipulation, streamlining dispensing operations, and tailoring treatments for individuals, all of which contribute to superior output levels, heightened accuracy, lessened chances of impurity introduction, and better protection for personnel. To illustrate this trend, data shared in September 2024 by the International Federation of Robotics, a professional, non-profit body headquartered in Germany, showed that Europe's manufacturing sector saw a 9% surge in new industrial robot placements, setting a novel peak at 92,393 installations. Eighty percent of these, amounting to 73,534 units, were situated within the European Union, marking a 2% year-over-year increase. Consequently, the rising incorporation of robotics in drug making is set to be a key factor accelerating the expansion of the biopharma automation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

Which Emerging Trends Are Transforming the Automation In Biopharma Industry Market in 2025?
A significant trend observed within the biopharma automation sector involves the proliferation of sophisticated technological progress, wherein major market participants strategically concentrate on innovating their offerings to solidify their competitive standing. Illustratively, in September of 2022, PerkinElmer Inc., an American provider of scientific tools and expertise, introduced the Cellaca PLX Image Cytometry System, representing a state-of-the-art automated apparatus engineered to streamline both the investigation and production phases associated with cell and gene therapies. Facilitating an automated process, the Cellaca PLX framework empowers scientists to assess vital characteristics of cellular specimens, such as identification, enumeration, and overall quality parameters. This comprehensive unit merges the necessary hardware for image cytometry, proprietary software, verified consumable supplies, and comprehensive, auditable data documentation, thereby substantially reducing the demands related to system setup and user instruction.

What Are the Key Segments in the Automation In Biopharma Industry Market?
The automation in biopharma industrymarket covered in this report is segmented -

1) By Technology: Automation Technology; Digitization Technology
2) By Component: Automation Hardware; Automation Software; Services Project Phase; Services Operation Phase
3) By Application: Clinical Phase; Drug Discovery Phase; Production Phase

Subsegments:
1) By Automation Technology: Process Automation; Laboratory Automation; Robotics And Artificial Intelligence; Control Systems; Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization; Electronic Lab Notebooks (ELN); Cloud Computing; Internet Of Things (IoT) In Pharma; Digital Twin Technology

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Who Are the Key Players Shaping the Automation In Biopharma Industry Market's Competitive Landscape?
Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton dic*kinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

What Geographic Markets Are Powering Growth in the Automation In Biopharma Industry Market?
North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12704

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.